FDA Warning Letter — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
The FDA took a Warning Letter action against Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) on July 11, 2024 (Lianyungang, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
- Date
- July 11, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Lianyungang (China)